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   Introduction
Within the framework of the project “Strengthening advocacy function of CSOs in Montenegro 
through developing policy-oriented capacities of Coalition for Social Changes”, implemented by the 
Monitoring Center - CEMI in cooperation with Juventas and Cazas, formed a Coalition for Social 
Changes, comprised by ten NGOs from Montenegro. This coalition has prepared recommendations 
for the improvement of policies in the areas of health, social care, employment and education, which 
are regulated by the Poverty Alleviation and Social Inclusion Strategy (PASIS). This document 
establishes a series of activities and measures with the aim of preserving and improving the health of 
citizens. To such an end, a set of laws and bylaws have been adopted, which regulate the prevention 
and control of chronic non-communicable diseases, including malignant tumors. 
Achieving this goal includes measures of prevention and early detection of malignant neoplasms for 
which there are valid and acceptable screening tests: breast, cervical and colorectal cancers. Currently, 
prevention and early detection of breast and cervical cancer is being implemented in Montenegro, 
while the implementation of the legally established measures of prevention and early detection of 
colorectal cancer are not fully implemented. 
Today, when we know that 80-95% of patients with colorectal cancer can be cured if diagnosed 
early through organized and effective system of early detection, it is expected that the implementation 
of the legally established measures, would have a significant impact in the reduction of morbidity and 
mortality caused by this disease. 1    
The recommendations of this study include measures that significantly contribute to improving the 
health of the population, because proper prevention enables detection of malignant colon tumors in 
the early and limited stage, i.e. in the stage of so-called pre-malignant lesions or early cancers, when 
the prospects for curing are great. In this way, health care is provided to all patients who are at risk of 
getting the disease, including the socially vulnerable, thus contributing to equitable healthcare.
For purposes of this study and other studies that monitor the implementation of PASIS, CATI 
(computer-assisted telephone interviewing) survey was conducted on a sample of 1050 citizens of 
Montenegro, who were asked to express their views on health, education, levels of social exclusion and 
employment policies in Montenegro. Further, in-depth interviews with representatives of medical 
institutions and decision makers in this area were conducted. 
This study is structured in 5 chapters. 
The first part gives a brief overview of institutions and organizations that are involved with the 
health policies in this area. 
The second part provides an analysis of the normative framework regulating the prevention 
1 Rob Hicks, Trisha Macnair, „Bowel Cancer“, BBC Health,  http://www.bbc.co.uk/health/physical_health/conditions/in_depth/can-
cer/typescancer_bowel.shtml, January 2010,  accessed on December 29th, 2010
  ACS American Cancer Society, http://www.fascrs.org/aboutus/press_room/backgrounders_and_tip_sheets/colorectal/ accessed on 
December 10th, 2010 
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and early detection of colorectal cancer in Montenegro. Further, strategic documents that provide 
additional measures for regulating health policies are analyzed.
The third part presents the analysis of the situation, which contains a definition of colorectal 
cancer and the way health care is realized in terms of this disease. Special attention is paid to risk 
factors for colorectal cancer, classification of patients by degree of risk and the modalities of screening 
for these patients. Finally, this part provides an overview of the pilot project on the importance of 
early detection of colorectal cancer that was implemented in the municipality of Danilovgrad, by the 
Ministry of Health.
Comparative analysis of the prevention and early detection of colorectal cancer is provided in the 
fourth part, where it is demonstrated how this area is regulated in Serbia, Croatia and Bosnia and 
Herzegovina. 
The fifth part of the study contains the summary of the study, with general assessment of the 
situation and specific recommendations for the improvement of policies regulating the prevention and 
early detection of colorectal cancer in Montenegro.  
Prevention and early detection of colorectal cancer in Montenegro 
7
I Institutional framework 
1.1. State Institutions 
Ministry of Health  
Ministry of Health as an umbrella institution for health issues in Montenegro organizes its activities 
through sectors and departments. 
The Department of healthcare carries out activities related to the implementation of health policies, 
which regulate the general principles of the system in the areas of primary, secondary and tertiary 
health care. This department monitors the reports on health condition of the population prepared 
and submitted by the Institute for Public Health, and according to the reports, organizes measures in 
order to ensure adequate healthcare and monitors the implementation of laws and other regulations 
related to the health of population which are under the jurisdiction of the Ministry. 
The Department for the management of healthcare, among other, implements activities related 
to the preparation of health policies, development and improvement of the health system through 
utilization of resources, management and organization, as well as supervises the work of the Health 
Insurance Fund. 
The Department for European Integrations and International relations performs activities that 
are related to the implementation of activities and obligations of the Ministry within the process of 
accession to the European Union in the field of healthcare, providing information on the preparation 
and implementation of Action plans of relevance to the healthcare, definition of donor programs, 
cooperation with relevant bodies and institutions regarding the EU accession process and monitoring 
of the activities and obligations of the Ministry in the process of the EU accession.  
 Institute for Public Health 
The Institute for Public Health (hereinafter the Institute) is a highly specialized health institution 
at the tertiary level of healthcare, which ensures the preservation and improvement of the health of 
all citizens of Montenegro. 
In the field of prevention, the Institute monitors the implementation of preventive programs and 
to that aim coordinates the work of all health institutions in Montenegro. Additionally, the Institute 
analyzes and researches epidemiological situation of communicable and noncommunicable diseases of 
broader socio-medical significance, and proposes and implements measures in the field of preventive 
care. The Institute also collects and processes, in accordance with the Law on data collections in 
the field of health, defined health statistics, and manages health data of interest for the Republic. 
Activities of the Institute in the area of prevention also include epidemiology of communicable and 
massive noncommunicable diseases, as well as improvement of health-information system and health 
statistics. 
Within the framework of this study, the Institute of Public Health is, according to the Law on data 
collections in the field of health, a competent body for the management of the Registry for malignant 
neoplasms.  
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Health Insurance Fund of Montenegro 
Health Insurance Fund of Montenegro is an institution that ensures the provision of health care 
rights and insurance, with the mail goal of financing the health care of the entire population. As part 
of its activities, the Fund, inter alia, performs following activities:
•	 Prepares	plans	and	programs	for	the	implementation	of	development	policies	and	
improvement of healthcare, laws and other regulations on conditions, procedures and manner 
of exercising the rights to health care and health insurance
•	 Provides	expert	assistance	to	their	beneficiaries	and	protects	their	interests	
•	 Implements	international	agreements	from	the	area	of	healthcare	related	to	health	insurance
•	 Concludes	agreements	with	health	institutions	and	other	organizations	in	relation	to	
the provision of health services to insured persons and monitors the implementation of 
such contracts.
 Clinical Center of Montenegro 
Public health facility Clinical Center of Montenegro (hereinafter: the Clinical Center) is a highly 
specialized medical and scientific institution and teaching facility of the Medical University in 
Podgorica.
Clinical Center of Montenegro provides healthcare for the citizens in various fields, including 
internal medicine, general surgery, oncology and radiology, clinical genetics and laboratory diagnosis. 
Activities at the Clinical Center are carried out in organizational units, among which:
1. Intern Clinic, which includes the Department of Gastroenterology 
2. The Center for Abdominal Surgery, which operated under the jurisdiction of the Surgical Clinic 
and includes the Department of colorectal surgery.
3. Oncology Clinic, which comprises of the Department of chemotherapy, Department of 
Radiotherapy and Nuclear Medicine Department.
4. Center for Medical Genetics and Immunology, which includes the Department of Medical 
Genetics and Department of Immunology
5. Center for Clinical and laboratory diagnosis which consists, among other, of the Department for 
biochemical Diagnostics as well as the Department for hematological diagnosis.
Scientific research activities at the Clinical Center are particularly diverted on clinical researches 
of specific pathological conditions, etiological factors and treatment of diseases and fundamental-
medical research. Scientific research activities at this center are performed on the basis of established 
programs and projects, through previously established teams, examining the field of applied medicine 
through linking clinical work with research in the laboratory. 
Clinical Center, as a teaching facility of the Faculty of Medicine provides the implementation of 
plans and programs of the University of Montenegro-Faculty of Medicine in accordance with the law, 
guidelines and directives of the European Union.
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II Normative framework 
Ministry of Health, Labor and Social Care of the Republic of Montenegro, adopted in July 2007, 
Poverty Alleviation and Social Exclusion Strategy (hereinafter referred to as „PASIS”).   This strategic 
document is based on the Strategy of Development and Poverty Alleviation, which was adopted by 
the Government of Montenegro in November 2003. The Ministry of Health, Labor and Social Care 
in January 2007, formed an expert group with the task of analyzing the degree of implementation 
of the Strategy of Development and Poverty Alleviation and evaluating the then current situation, 
and proposing the necessary policies and programs in terms of reducing the poverty of vulnerable 
groups in the areas of education, health, social protection and employment, in accordance with the 
international standards. 
The project priority proposals of local and regional significance, provided by the municipalities to 
the Ministry of Health and Social Care, served as a basis for the PASIS. 2The strategy was drafted in 
accordance with the Agenda of Economic Reforms and Development of Montenegro 2007-2011, 
Sustainable Development Strategy and the European Partnership Action Plan. Within the PASIS 
framework, the area of health is recognized as a priority in terms of the implementation for the 
period 200702011, while the planned activities are aimed at health promotion, disease prevention 
and strengthening of the principles of equality, accessibility and affordability, ensured within the 
framework of sustainable development. 
According to the PASIS, the health care system of Montenegro ensures the preservation and 
improvement of the health of the population, achieved through the implementation of a series of 
activities and measures aimed at health promotion, disease prevention, treatment and rehabilitation of 
patients. The main goals defined by the PASIS, based on these principles are:
•	 Preservation	and	improvement	of	public	health	
•	 Defining	national	goals	for	reducing	inequalities	in	access	to	health	care	system
•	 Improving	the	access	to	medical	care	for	the	disadvantaged	
•	 Reduction	of	inequalities	in	the	health	care	system	through	improvement	of	the	health	
of vulnerable groups 
One of the priorities of reform of health sector, as defined by the PASIS, is the change of attitudes 
towards health. This reform is based on the principles of health policies aimed at raising awareness of 
citizens on responsible patterns of behavior in terms of health. In addition, the document establishes 
that the provision of health care system needs to be ensured in the most acceptable and most equitable 
way, while its development needs to be harmonized with the development trends from European 
health care systems. Pursuant to the established reforms, the emphasis of the health policy is placed 
on the prevention of chronic noncommunicable diseases, as one of the leading causes of morbidity 
and mortality worldwide. 
Within the framework of PASIS implementation, the Strategy for the Prevention and Control 
of chronic noncommunicable diseases3  was prepared and the Law on data collections in the field of 
health care adopted.4  Additionally, of importance for the implementation of PASIS goals of great 
2 Poverty Alleviation and Social Exclusion Strategy, Ministry of Health, Labor and Social Care, Podgorica, http://www.minradiss.
gov.me/biblioteka/strategije, July 2007, accessed on November 15th, 2010
3 Strategy for the Prevention and Control of Noncommunicable Diseases, Ministry of Health, Work and Social Care, November 2008
4 The Law on data collections in the field of health care “Official gazette”, number 80/08
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importance are previously passed the Law on health insurance 5 and the Law on health care6 on health 
care , while for the latter an amendment is being prepared. 7
The Government of Montenegro has endorsed in November 2008, the Strategy for the Prevention 
and Control of chronic noncommunicable diseases, which include following diseases: ischemic heart 
diseases, cerebrovascular diseases, malignant neoplasms, diabetes mellitus and chronic obstructive 
pulmonary diseases. This strategic document is in accordance with the European Strategy for 
the Prevention and Control of chronic noncommunicable diseases, drafted by the World Health 
Organization in 2006. The need for the preparation of this strategy in Montenegro is based on the 
following facts: 
•	 In	 the	 structure	 of	 total	mortality	 of	 the	 population	 in	Montenegro,	 the	 share	 of	 chronic	
noncommunicable diseases is about 75%. 
•	 The	 share	 of	 chronic	 noncommunicable	 diseases	 in	 the	 total	 incidence	 of	 Montenegrin	
population is increasing. This is primarily due to the aging of the population and the characteristic 
of society in transition, i.e. the socio-economic and environmental determinants of health which 
foster the practice of inadequate health lifestyles (patterns of behavior) among the population of 
Montenegro
•	 Significant	 loss	of	 life	age	caused	by	premature	deaths,	as	well	as	 significant	disability	and	
absenteeism caused by chronic non-communicable diseases, represent a large economic burden for the 
state. 
•	 Significant	number	of	risk	factors	for	the	development	of	major	chronic	noncommunicable	
diseases has been identified, while many of these risks are preventable, mostly through practicing 
health lifestyles. 8 
According to Monstat, the Statistical office of Montenegro from 2006,9   malignant neoplasms 
are, after cardiovascular diseases, a leading cause of death in Montenegro. In 2006, in Montenegro 
974 persons died from malignant neoplasms. Among the most common causes of mortality from 
malignant neoplasms in Montenegro, colorectal cancer occupied second place for men (13.9%) and 
third for women (8.3%). 
Objectives set by the Strategy for the Prevention and Control of chronic noncommunicable diseases 
include the reduction of morbidity and mortality from chronic noncommunicable diseases, including 
some forms of malignant neoplasms, as well as the improvement of quality of life. The realization of 
these objectives when it comes to malignant neoplasms is planned through the establishment of the 
National Program for the Prevention and Control of malignant neoplasms, which would include 
measures of primary prevention and early diagnosis of the disease as well as reduction of exposure to 
risk factors, particularly for malignant neoplasms for which there are valid and acceptable screening 
tests. 
5 The Law on health insurance „Official gazette“, number 29/05
6 The Law on health care „Official gazette“, number 39/04
7 The information on the implementation of PASIS, Ministry of work and social care, http://www.minradiss.gov.me/biblioteka/strate-
gije, June 2010, accessed in November 2010
8 The strategy for the Prevention and Control of chronic noncommunicable diseases, Ministry of Health, Work and Social care,
9 Monstat, „Leading death causes according to gender in Montenegro”, 2006
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With the aim of carrying out the planned reforms of the health system, the Government of 
Montenegro has developed following strategic documents: Health policy in Montenegro until 2020, 
which served as a basis for legislative, policy oriented and action programs, as well as the Strategy 
for Healthcare Development.10  Furthermore, for the purposes of the implementation of Healthcare 
System Improvement Project, the World Bank loan was acquired. These funds ensure, inter alia, the 
development of primary health protection and improvement of secondary and tertiary healthcare 
sectors. 11
Complementary to the aims of the Project, the following acts were adopted: 
•	 Regulation	on	the	extent	of	rights	and	standards	of	health	care	and	mandatory	health	insurance	
(Official gazette, number 79/05), 
•	 Protocol	on	standards,	norms	and	ways	of	accessing	primary	healthcare	protection	through	
chosen team or chosen doctor (Official gazette, number 10/2008),
•	 Master	plan	for	Development	of	Healthcare	in	Montenegro,	for	the	period	2005-2010
•	 Master	plan	for	Development	of	Healthcare	in	Montenegro,	for	the	period	2005-201012  
With the adoption of the Protocol on standards, normative and ways of accessing primary healthcare 
protection through chosen team or chosen doctor, the necessary conditions for the implementation 
of the main goals of the Strategy for chronic noncommunicable diseases are established, furthered by 
the definition of certain obligations as defined by the Law on Health Care. 
Article 1 of the Law on Health Care defines healthcare as a set of measures and activities aimed 
at preserving, protecting and improving health, prevention and control of diseases and injuries, 
early detection of diseases, timely treatment and rehabilitation. Consequently, prevention and early 
detection of diseases is associated with the implementation of prevention and early detection of 
cancer at the level of primary health care. More specifically, the Article 33 of this Law further defines 
health services that are implemented at the primary health care level and include:
1) Promotion of healthy lifestyles, including healthy nutrition of population
2) Detection, prevention and control of malignant diseases
In terms of malignant neoplasms, the objectives of the Strategy for the Prevention and Control 
of chronic noncommunicable diseases include screening tests for: breast, cervical, colorectal, prostate 
and skin malignant neoplasms. The Law on Health Insurance establishes additional medical measures 
and procedures of prevention, control and early detection of diseases, with special emphasis on 
providing the health care to persons suffering from malignant diseases (Article 17, paragraph 1, item 
6). Furthermore, the Article 12 of the Regulation on the extent of rights and standards of health care 
and mandatory health insurance13 , regulates services provided by the chosen doctor at the level of 
primary health care, which include preventive screening tests for early detection of cervical cancer 
(PAP test), breast cancer, as well as breast examination and mammography. Since prevention and 
10 The Government of Montenegro, The Strategy for Healthcare Development, www.mzdravlja.gov.me/files/1158667679.doc, 2003, 
accessed on November, 3rd 2010
11 Ministry of Health, http://www.mzdravlja.gov.me/vijesti/37766/177975.html, November 19, 2009, accessed on December 15 2010
12 Ministry of Health, http://www.mzdravlja.gov.me/rubrike/strategija-razvoja-zdravstva-crne-gore/97487/MASTER-PLAN-RAZ-
VOJA-ZDRAVSTVA-CRNE-GORE-ZA-PERIOD-2010-2013.html, June 10th 2010, accessed on November 12th, 2010
13 Regulation on the extent of rights and standards of health care and mandatory health insurance,  October 13, 2005
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early detection of colorectal cancer are not fully provided in Montenegro, it is necessary on the one 
hand to extend the normative framework and on the other to implement existing legal provisions and 
integrate prevention and early detection of colorectal cancer into the primary health care system.
The adoption of a series of laws in the area of health imposes a need for the establishment of 
mechanisms which would regulate collection of data that is crucial for the monitoring of the field 
of health care, especially in terms of the prevention, monitoring and control of colorectal cancer. 
Calman-Hine report points out the importance of comprehensive data collection for cancer, which 
enables monitoring the effectiveness of prevention and treatment of this disease, as well as time trends 
related to the epidemiology of this disease. 14  In addition, the existence of a comprehensive data 
system for colorectal cancer enables precise determination of the etiology of the disease in a patient, 
which is of critical importance for both the prevention and control of the disease. 15 
While the Montenegrin legislation envisages the preparation of collection of data for malignant 
neoplasms – Registry, the legal liabilities however are yet to be applied. In result, the Registry for 
malignant neoplasms in Montenegro is still not established. On December 26th, 2008, the Law on 
data collections in the field of health care was adopted, which regulates that the data collections are 
used for the monitoring and the analysis of the public health, planning and programming of health 
care and for assisting government agencies in conducting health policies.16  The Institute for public 
health is the competent body for managing the data collections, regulated by Article 4 of this Law. 
Register as a special data collection is maintained for diseases of major socio-medical significance 
and infectious diseases, including the malignant neoplasms (Article 9). In addition, Article 12 of this 
Law provides the establishment of data collections at the level of prevention within the non-hospital 
care. The law also regulates the procedures of updating the data collections, by which the healthcare 
providers are required to submit data from medical records to the body in charge of managing the data 
collections, through reports and statements, including the reports on malignant neoplasms. 
For now, despite a clear, legally binding obligation, the Registry for malignant neoplasms in 
Montenegro has not been established. Although the development of the Registry is planned for 
this year, the lack of the Registry has broader implications, since it prevents the fulfillment of 
legal obligations, implementation of activities and achievement of goals that are established by the 
strategic documents. In accordance with the obligations set out by the Law on Health insurance, the 
abovementioned goals of the Strategy for the Prevention and Control of chronic noncommunicable 
diseases and the PASIS, it is obvious that the prevention and early detection of colorectal cancer have 
not yet been systematized in Montenegro. 
III Analysis of the current situation 
According to the data of World Health Organization, set out in the European Strategy for the 
Prevention and Control of noncommunicable diseases17   for year 2006, out of 150.322.000 people 
14 Calman Hine report, April 1995, page 7 http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/
digitalasset/dh_4014366.pdf, accessed on December 5th, 2010
15 D Manser, D.F Levine, D.F.H Pheby, R.W Pitcher, “ Colorectal cancer registration: the central
importance of pathology”, April 19, 2000 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1731103/pdf/v053p00875.pdf, accessed  on 
November 19th, 2010
16 Article 2 of the Law on data collections in the field of health care, Official Gazette, number 80/08
17 Anna Ritsatakis, Peter Makara, „Gaining Health: Analysis of policy development in European countries for tackling noncom-
municable diseases“, World Health Organization, Copenhagen, 2006. http://www.euro.who.int/__data/assets/pdf_file/0018/105318/
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suffering from chronic noncommunicable diseases in Europe, 17.025.00 or 11% were diseased from 
malignant neoplasms. During the same year, out of total 9.564 million persons who died from the 
chronic noncommunicable diseases, 1.855.000 or 19% died from malignant neoplasms. Therefore, 
malignant neoplasms were in 2006, third in morbidity from all chronic diseases in Europe, after the 
diseases of circulatory system and neuropsychiatric diseases, and second in terms of mortality, after 
the diseases of circulatory system. 
Due to the lack of the Registry for malignant diseases, it is not possible to determine either the 
prevalence or incidence of malignant diseases in Montenegro. Currently, the only source of data on the 
prevalence of this disease and the mortality rates in Montenegro are publications from Monstat. After 
cardiovascular diseases, malignant neoplasms are the most common cause of death in our country. 
According to MONSTAT, 974 persons died of malignant neoplasms in Montenegro in 2006, while 
891 persons died in 2009, from same diseases.18   The mortality rate for malignant disease in 2006 
was significantly higher in males (573 or 58.8% for men: 401 women or 41.2%), while in 2009, a 
slight increase in mortality rates among was recorded (504 or 56.5% for male: 387 women or 43.5%). 
Additionally, the number of deaths from malignant neoplasms in Montenegro, in relation to the 
total number of deaths for the period from 2001 to 2006, it can be noticed that the number has not 
changed significantly. (Table 1)
Table 1.   Mortality rate for malignant neoplasms 2001-2066
__________________________________________________________________________ 
                               The number of diseased and mortality rate in Montenegro in percentage 
Year                           2001       2002       2003        2004       2005       2006
Malignant neoplasms           16,3        18,1        16,9         17,0         17,6       16,3
Source: Monstat 
According to estimates of tumor incidence and mortality in Europe, 19  the standardized mortality 
rate for 2006 in Montenegro amounted to 209.3 for men and 119.3 women per 100,000 inhabitants 
(Table 2), while for the same year, in Serbia, total standardized mortality rate (for men and women) 
was significantly higher - 257, 8 (men) and 159.0 (women) per 100,000 inhabitants. Based on these 
data we can say that Montenegro belongs to a group of countries with medium-high mortality rate 
from malignant neoplasms for men and a low mortality rate for women.
e92828.pdf, accessed on December, 5, 2010
18 Statistical office of Montenegro - Monstat, “Montenegro in numbers”, Podgorica 2010
19 J Ferlay, P Autier, M Boniol, M Heanue, M Colombet and P Boyle, „The estimates of cancer incidence and mortality rates in 
Europe“, Annals of Oncology 2007, Volume 18, No 3: 581-592
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Tabela 2.   Standardizovana stopa mortaliteta 1:100.000 od malignih neoplazmi u izabranim 
evropskim državama
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According to the available data from health statistics for year 2006 in Montenegro, the rate of 
malignant neoplasms in the number of people who were treated in hospitals is very high. With a share 
of 8.7% of all cases of hospital discharges, malignant neoplasms represent the fourth most common 
reason for hospitalization in 2006. In 2009, colorectal cancer represents 9.5% of all hospital discharges 
for malignant diseases. 20
Consequently, malignant neoplasms represent a significant burden of the health system, primarily 
due to costs of hospitalization and treatment of primary malignancies and metastases of the disease. 
3.1 Colorectal cancer
The two main characteristics that define cancer are uncontrolled growth of cells and tissue invasion. 
Uncontrolled cell growth without the tissue invasion is a characteristic of benign neoplasms. Malign 
neoplasms of epithelial tissue are called carcinomas, while malignant neoplasms of mesenchymal 
tissues are called sarcomas. Colorectal cancer is a disease where cells lining the colon and rectum 
become abnormal and begin to divide without control, forming a mass called tumor (colon and 
rectum are parts of the digestive system of human body). During this process, colorectal cells invade 
and destroy the surrounding tissue, and can also spread into the lymph system and bloodstream, after 
which the disease becomes incurable and leads to death. 
Tumors with distal spread of 15 cm or less (measured by the rigid proctoscopy) from the anal 
margin are classified as rectal, while proximal from such border are tumors of the colon. The most 
common site of metastasis of colorectal cancer is the liver. The diagnosis of colorectal cancer requires 
a biopsy during rectosigmoidoscopy or colonoscopy and histopathological confirmation. 
Colorectal cancer represents a major health problem due to the high incidence, which in the 
most countries over the past three decades is on the rise. According to the data from American 
Cancer Society (hereinafter referred to as ACS) for 2010, colorectal cancer is the third most common 
type of cancer in men (after prostate and lung cancers) and women (after breast and lung cancers). 
Additionally, colorectal cancer is the second leading cause of death of all malignant neoplasms in the 
US. During 2009 in the US, 146.970 new cases of colorectal cancer were registered (106 100 cases of 
20 Response to a request for access to information, number 01-8016.
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colon cancer and 40.870 cases of rectal cancer), while 49.920 people died from this disease. 
As noted above, due to the lack of Registry for malignant diseases it is not possible to determine 
the prevalence, incidence and mortality rates for colorectal cancer in Montenegro. Such data exists 
only for 2006, where the disease ranks as second in men and third among women in terms of incidence 
and cause of mortality in our country. (Table 3)
Tabela.3 Najčešće maligne neoplazme kao kao uzrok smrti kod muškaraca i žena, Crna Gora, 
2006.               
___________________________________________________________________________
                              Men                                                   Women
Localization      mortality                  /                      Localization         mortality  
Pluća                    74,9                                                   Dojka                  27,8
Kolorektum          15,0                                                   Pluća                   21,0
Prostata                15,0                                                   Kolorektum          7,4
Stadardized rate  100000
Source: Monstat 
3.1.1 Colorectal cancer and Healthcare system in Montenegro
Diagnosis and treatment of patients with colorectal cancer in Montenegro is performed in 
institutions of secondary and tertiary health care. Subspecialists gastroenterologists perform 
examinations of patients referred by chosen doctors from Health Care Centers, and in accordance 
with current clinical practice guidelines, refer patients to invasive endoscopic diagnosis that includes 
colonoscopy. Invasive endoscopic diagnostic endoscopy is performed by the gastroenterologist in 
laboratories, while in the case of diagnosis of colorectal cancer, further evaluation and treatment of 
the disease is in the competences of gastroenterologists, gastrointestinal surgeons and oncologists.
The National Program for the Prevention and Control of malignant neoplasms has not been 
established in Montenegro, which would include measures of primary and secondary prevention of 
colorectal cancer, although the adoption of such a program is presumably planned for the third quarter 
of 2011. Preventive examinations undertaken by the chosen doctors at the primary health care, which 
do not include examinations of patients with previously diagnosed colorectal cancer, are foreseen by 
the Article 33 of the Law on Health Care and the goals of the Strategy for the Prevention and Control 
of chronic noncommunicable diseases, but not implemented. The implementation of preventive 
screening for the prevention and early detection of colorectal cancer can also be achieved through 
expansion of the Article 12 of the Regulation on the extent of rights and standards of health care and 
mandatory health insurance. In this context, the proposals provided in this study are complementary 
to aspirations for the establishment of an adequate system of prevention and early detection in the 
general population with an average (normal) risk of developing colorectal cancer, as well as for the 
persons with an increased risk of developing this disease. 
The best way of treating cancer is the primary prevention, i.e. prevention of the development of 
disease through the elimination of harmful effects or by promoting positive behavior patterns. Health 
education, proper diet and lifestyles and other measures of primary and secondary prevention can 
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reduce the incidence of colorectal cancer, and in most cases the disease can be detected at an early 
stage when treatment results are significantly better. Researchers estimate that the application of all 
that is known about the cancer prevention can help prevent the development of these diseases in 
nearly two-thirds of the cases. 21   
The prevention of cancer however is not always possible, since not all causes for the development 
of this disease are known or avoidable. Consequently, secondary prevention or early detection is still 
of great importance. When the disease occurs, the success of the treatment depends primarily on the 
degree of expansion of the disease at the moment of the diagnosis. On the basis of existing evidence 
on the effectiveness and the utilization of available methods for early detection, screening programs 
for cervical, breast and colon cancer are now generally accepted and recommended.
Symptoms that indicate the existence of colon cancer are occult or overt bleeding, changes in 
the intestinal emptying, weight loss, abdominal pain and anemia. Patients who have some of these 
symptoms are not included in the screening program, but are instead redirected for diagnosis.   
3.2 Risk factors for developing colorectal cancer
The exact causes of colorectal cancer development are unknown. However, studies have shown that 
certain risk factors are associated with an increased chance for developing this disease, including the 
following:
Age: Colorectal cancer is more common in older people. Although the disease can occur at any age, 
most patients with colorectal cancer are over 50 years of age. The risk of developing colorectal cancer 
increases significantly after 40 years of age, while 91% of all cancers are detected in people older than 
50 years. 22  Every person over 50 years is at 4.8% of risk of suffering from colorectal cancer by 74 years 
of age, or at 2.3% of risk of dying from colon cancer.
According to Monstat, the age specific mortality rates of the colorectal malignant neoplasms are 
somewhat more evenly distributed with a significant increase only after the age of 65. Thus, from the 
total number of deaths caused by the colorectal malignant neoplasms, 38.2% died before the age of 65 
and 73.5% before the age of 75 years of age.
Tabela 4. Age specific mortality rates for chosen malignant neoplasms in Montenegro, 2006 . 
21 Cornuz J, Auer R, Senn N, Guessous I, Rodondi N. „Prevention and Screening“, National Health Institute USA,  December  2010. 
     Otto S. Lin „Early detection improves chances to beat colorectal cancer“, Institute for digestive diseases, Virginia, 2003
22 Ibid.
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Polyps: 
Polyp is a tissue mass that juts out into the lumen of the intestine, and represents the most common 
benign tumor of the colon. Polyps are classified as neoplastic or adenomas, which have a malignant 
potential and nonneoplastic polyps. The asymptomatic form is present in 12% of the population, while 
in people aged over 70 years up to 40%. The incidence of neoplastic polyps-adenomas is parallel to the 
incidence of colon cancer. All adenomas sooner or later transform into cancer, which is a well-known 
“adenoma-carcinoma sequence” that lasts on average 7-10 years. This means that most colorectal 
cancers have a slow genesis and that there is enough time for polyps to be removed through measures 
of secondary prevention, before the malignant transformation, resulting in the cease of “adenoma-
carcinoma sequence”. 
Familial adenomatous polyposis is an autosomal dominant mutation of tumor suppressor gene 
(APC), from chromosome 5p. Familial adenomatous polyposis is responsible for about 1% of colon 
cancer, and this syndrome includes Gardner’s and Turcot syndrome. In adolescence, some 100 and 
often even 1000 adenomas are developed in colon, which are always present in rectum. The patient 
usually dies from the colon cancer before the age of 40. 
Nonneoplastic polyps are very common, especially metaplastic, which account for 75% of polyps 
in patients over the age of 40. This group includes inflammatory as well as familial hamartomatous 
polyposis syndrome (juvenile polyposis and Peutz-Jeghers syndrome). 
Peutz-Jeghers syndrome is an autosomal dominant inherited disease characterized by intestinal 
hamartomatous polyps in junction with mucocutaneous pigmentation. Patients with Peutz-Jeghers 
syndrome are at a 15 times greater risk of developing intestinal cancer that general population. 
Juvenile polyposis occurs in the first decade of life, and is inherited in an autosomal dominant 
(SMAD4 gene mutation). Juvenile polyps are usually localized in the rectum. In solitary polyps there 
is no significant risk for developing cancer, but with multiple polyps (>5), colon polyposis syndrome 
is carries 10% of risk for the cancer development. 
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant genetic condition, 
present in 2-5% of patients suffering from colorectal cancer. There is no case of polyposis development. 
23
Personal anamnesis: A person who is already diagnosed with colorectal cancer is at an increased risk 
of developing colorectal cancer for a second time. Studies have also demonstrated that some women 
with a history of ovarian, uterine or breast cancer have a higher chance of developing colorectal 
carcinoma. 
Family anamnesis: First-order relatives (parents, twins or children) of a person who has had a 
colorectal cancer in most cases will develop this form of cancer, especially if a family member had 
cancer at an early age. In the case of a large number of patients from the family diagnosed with 
this disease, the chances of developing colorectal cancer increases even more. One quarter (25%) of 
patients have a family anamnesis of colorectal cancer, of which 15% are of first-order relatives. 24   
23 Donna Myers „ Colon polyps and cancer risk“, February 2007 
     Obren Popović, Mihajlo Božanić , „Polyps and colorectal polyposis” Interna medicina, 2003
24 Simona Valean, P. A. Mircea, Doinita 
Crisan, Magda Petrescu, “ Sporadic Colorectal Cancer or Hereditary Lynch Syndrome: Anamnestic Epidemiologic Study Using 
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Diet: Many studies indicate that the development of colorectal cancer may be associated with 
an increased intake of red and processed meat, as well as the low intake of whole grains, fruits and 
vegetables. 25  Of all the external factors, nutrition is given utmost importance. David Burkitt in 1970 
has pointed out that rural Africans suffer from much less colon cancer than the urban population 
of the United States. Through the examination of geographical distribution of colorectal cancer, the 
importance of nutrition in the development of colorectal cancer has been further outlined. Burkitt 
noted that the nutrition of the population of countries with the high risk for developing the colorectal 
cancer is dominant in refined carbohydrates, fats and meat products while lacking in the intake of 
fresh fruits, vegetables and foods rich in cellulose and fibrous materials.26  In developing countries 
or countries with lower incidence of colorectal cancer eating habits are significantly different, with 
population having more frequent emptying of the colon and voluminous stool, which can have a 
protective role in the development of colon cancer. Recent research has demonstrated a significant 
protective role of fresh fruits and vegetables, fish, poultry meat, fiber, broccoli and cabbage, as well 
as the direct link between fat intake from animal sources and red meat, and an increased risk of 
developing colorectal cancer.
Obesity: Obesity, defined as body mass index (BMI) greater than 30kg/m2, is associated with 
about 10% of all cancers.27  BMI is with both men and women in significant direct correlation with 
and increased incidence and mortality rate for cancers of the esophagus, stomach, colon, gallbladder 
and pancreas. Interestingly, the effect of obesity in women is much more pronounced during the 
premenopausal age, whereas the incidence of colorectal cancer is twice as high in obese persons. This 
correlation is lost at the start of menopause. The relative risk of developing colorectal cancer is about 
50% higher in obese men and women. 28 
Physical activity: Research suggests that physical inactivity may be associated with an increased 
risk of developing colorectal cancer. Conversely, people who exercise are at a lower risk of developing 
colorectal cancer. A large number of studies that analyzed nearly 13.000 people indicate a clear inverse 
correlation between physical activity and colorectal cancer. The relative risk for the development of 
colorectal cancer in people who regularly practice physical activity is about 50% lower than in the 
general population. Further, it is believed that the effect of physical exercise is higher in men and is 
applicable not to the rectum, but other part of the colon. The exact mechanism of how the physical 
activity prevents this cancer is not known. 29
Smoking: Tobacco use is the single most preventable cause of cancer in the world. It is estimated 
that smoking is the cause for 30% of the total deaths from malignant diseases.30  The results of 
epidemiological studies suggest that cigarette smoking increases the risk of developing colorectal 
Amsterdam and Bethesda Criteria”, BTCC Journal, April 2010. 
   Judith Karner-Hanusch, Martina Mittlböck, Thomas Fillipitsch, Friedrich Herbst, „Family history as a marker of risk for colorectal 
cancer: Austrian experience“ World Journal of surgery, 1997
25 Bruce WR, Wolever TM, Giacca A, “Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.“ Uni-
versity of Toronto, Canada, http://www.ncbi.nlm.nih.gov/pubmed/10965515,  2000, accessed on December 24th 201
26 Burkitt, D., “Causes of disease“ Lancet,  1969. 2: p. 1229–1231.
27 Deckelbaum RJ, Fisher EA, Winston M, Kumanyika S, Lau-
er RM, Pi- Sunyer FX et al. “ Overview of current issues in nutrition“, 1999; 100: 450-
456.                                                                                                                                                                         
28  Parkin DM, B.F., Ferlay J, Pisani P „Global cancer statistics: Globocan 2000. Int J Cancer, 2001. 94(2): p. 153-156
29 Meyerhardt,Jeffrey, Giovannucci Edward.  „“Physical Activity and Survival After Colorectal Cancer Diagnosis“, Journal of clini-
cal oncology,  August 2006. godine,  
30 WHO. Cancer prevention. Available at  http://www.who.int/cancer/prevention/en/
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cancer.31 
Primary prevention of colorectal cancer, which includes promotion and recommendation to reduce 
the preventable risk factors for the development of colorectal cancer and maintaining healthy lifestyles, 
including proper nutrition, reduction of obesity, moderate physical activity, is being implemented 
during the first examination by the chosen doctor, as well as organized programs and strategies at the 
national level.
3.3 Classification of patients according to the degree of risk for the development of colorectal 
cancer
Based on the Practical clinical guidelines in oncology from 2009 – NCCN (National Comprehensive 
Cancer Network), classification of patients according to the degree of risk for the development of 
colorectal cancer is established: 1) the average risk and 2) with an increased risk.  
I) Patients with an average risk of developing this disease include people from the age of 50 and 
older, with no symptoms, no history of existence of adenoma and colorectal cancer, inflammatory 
bowel disease and no family history. 
II) The group of patients with an increased risk of developing colorectal cancer include people 
with inflammatory bowel disease (chronic ulcerative colitis, Crohn’s long-term disease with colon 
cancer), genetic history (hereditary nonpolyposis colorectal cancer - HNPCC), familial adenomatous 
polyposis (FAP), including Gardner and Turcot syndrome, Hamartomatous polyposis syndromes 
(Peutz-Jeghers syndrome, juvenile polyposis), positive family history of colorectal cancer, colorectal 
adenoma, and a personal history of colorectal cancer, colorectal adenoma and breast, ovary and uterus 
cancer for women. 
Considering that the paragraph 2, Article 2 of the Regulation on the extent of rights and standards 
of health care and mandatory health insurance defines priority measures on the detection and 
elimination of risk factors of certain diseases, including malignant neoplasms, for the entire population, 
within the framework of this study modalities of screening for the prevention and early detection of 
colorectal cancer are proposed, based on the patients’ classification according to the degree of risk for 
the development of colorectal cance
3.4 Measures of secondary prevention of colorectal cancer 
Secondary preventive measures of colorectal cancer include screening tests with the goal of 
detection and removal of adenomatous colon polyps and detection of colorectal cancer in early 
(asymptomatic) phase. For screening measures to be socially acceptable, they must have an adequate 
degree of sensitivity and an acceptable price. Digital rectal screening is the cheapest method, but this 
method of screening detects only 10% of colorectal cancer incidences. Flexible rectosigmoidoscopy 
can detect about 50% of cases, while colonoscopy can detect up to 95% of colorectal carcinomas. 
Secondary prevention measures today in developed countries are given more and more attention, 
given that the adequate implementation can significantly reduce the incidence of colorectal cancer 
and significantly improve the treatment results. Most commonly used methods of screening are fecal 
occult blood test and colonoscopy.          
31 Edoardo Botteri, Simona Iodice,  Vincenzo Bagnardi,  “Smoking and colorectal cancer“, Journal of American Medical Associa-
tion, http://jama.ama-assn.org/content/300/23/2765.abstract 2008, accessed on January 10, 2011
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Fecal occult blood test                                                                                                                                                                    
Testing for the presence of occult blood in the stool is used to diagnose occult (invisible to the 
naked eye) blood in the stool. This test is based on the fact that the blood vessels on the surface of 
larger colorectal polyps or cancers are usually more fragile or more easily damaged during the passing 
of feces. Damaged blood vessels release a small amount of blood in the feces, which mostly cannot be 
noticed through the inspection of stool. Occult blood test detects blood in the stool through chemical 
reaction. Guaiac impregnated slide test has a sensitivity of 30-50%, so two samples each need to be 
taken from three consecutive stools. Immunohistochemical test has a sensitivity of 90%, so one sample 
is sufficient and does not require dietary restrictions.       
This test cannot determine whether the bleeding originates from the colon or other gastrointestinal 
tract (e.g. stomach). If this test is positive, it is necessary to do a colonoscopy in order to determine 
whether the cause of bleeding is cancer, polyp or for instance, boil, hemorrhoids, diverticulosis (small 
pouches that form in weak parts of the colon wall), or inflammatory bowel disease (colitis). 
Early detection of colorectal cancer by testing on the presence of occult blood in the stool in 
asymptomatic average risk population, proved to be a suitable method because of its simple application 
and low cost. In a large population and controlled studies, a positive test had between 1% and 5% of 
respondents. A positive test is an indication for further gastroenterological testing or colonoscopy. 
The predictive value of positive test in colorectal cancer is 5-10% and 20-30% for adenomas. People 
who were tested for the presence of occult blood in the stool should be warned that a negative test 
does not mean that the person does not have polyps or colon cancer. Experience in the application of 
the test for fecal occult bleeding, as a screening test for early detection of colon cancer, conducted in 
the United States, Great Britain, Sweden and Denmark led to a decline in relative mortality rates of 
colorectal cancer to 18-33%. 32 
Colonoscopy
Colonoscopy is a modern diagnostic method by which doctors can directly examine the entire 
colon. This procedure is performed using a colonoscope, a flexible, sterilized instrument of finger 
width, which due to its flexibility and optical fiber provides safe and accurate review of the entire 
colon. Colonoscopy can be performed with the use of mild sedatives (drugs, tranquilizers), analgesics 
(pain medications), and even with anesthesia. Examination takes 30-60 minutes, depending on the 
length and position of the colon. After the examination, the patient feels discomfort in the form of 
bloated abdomen. 
Colonoscopy allows for direct mucosal inspection of the entire colon, while simultaneously enables 
taking of biopsy samples or definitive treatment by polypectomy in the case of precancerous polyps 
and some malignant neoplasms in the early stages. In contrast to this, all other forms of screening, if 
positive, require colonoscopy as the follow up procedure. According to the American Cancer Society, 
research has shown that most patients preferred colonoscopy over other invasive diagnostic methods. 
33
Colonoscopy has its deficiencies. It is an invasive procedure and a large percentage of patients 
32 Zoran Krivokapić, “ Early detection of colorectal cancer“,  http://www.medicicom.com/content/view/282/64/, October 2009, ac-
cessed on January 13, 2011
33 Schroy PC 3rd, Lal S, Glick JT, et al. “ Patient preferences for colorectal cancer screening: How does stool. DNA testing fare? ”, 
2007;13:393–400.
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prefer non-invasive method of screenings for colorectal cancer. The efficiency of colonoscopy depends 
on the preparedness of the patient for review, as well as on the training of endoscopist to perform the 
procedure. Studies have shown that the percentage of false negative results of colonoscopy in terms 
of large adenomas (= 10 mm) ranges from 6% to 12%. 34  The percentage for cancers is about 5%. 35
Endoscopic procedures in addition to diagnostic can also be treatment methods. Colonoscopy, 
if the preparation is adequate and endoscopists trained can detect 90-95% of cases of malignant 
neoplasms, so today colonoscopy represents a „golden standard” for screening and diagnosis of cancer. 
3.5. The modalities of screening for people at average risk of developing colorectal cancer
The modalities of screening for people at average risk of developing colorectal cancer, according to 
the National Guide for doctors in primary health care for the prevention of cancer of the Ministry 
of Health of the Republic of Serbia includes the necessary risk stratification based on family and 
personal history. 36 
a) To all persons older than 50 years, who do not belong to any group at risk, it is necessary to offer 
participation in programs of early detection of colorectal cancer. /IA/37 
b) The optimal method of screening is the fecal occult blood test. /IIaB/  
c) Persons who have no family history of colorectal cancer need to be tested annually for the 
presence of occult blood in the stool. /IIaB/38
d) Persons with a positive test need to be referred to a secondary level institution, where colonoscopy 
is to be performed. 
e) Persons who express a desire to undertake endoscopic screening should be referred to an 
institution of the secondary level to undertake flexible rectosigmoidoscopy, once every 5 years. 
Experience in the application of the fecal occult bleeding test, as a screening test for early detection 
of colon cancer, conducted in the United States, Great Britain, Sweden and Denmark led to a decline 
in relative mortality rates of colorectal cancer to 18-33%. 39 
In Montenegro systematic preventive examinations at the primary health care level for early 
detection and prevention of colorectal cancer are not implemented for groups of patients with an 
average level of risk for the development of this disease. 
34 Rex DK, Cutler CS, Lemmel GT, et al. “Colonoscopy” , Gastroenterology 1997;112:24–28..
35 Bressler B, Paszat LF, Vinden C, et al. “ Colonoscopic miss rates for right-sided colon cancer: a population-based analysis”, Gas-
troenterology, 2004;127:452–456.
36 Each recommendation is stratified according to international standards, with Roman numbers I, II, IIa, IIb and III, while the de-
gree of proof is classified with letters A, B and C.
37 Proof or general consent on whether the given treatment or procedure is useful or efficient. The data is based on multiple random-
ized clinical studies or meta-analysis.
38 Proof or an opinion that is in favor of usefulness and effectiveness of the proposed measures. The data is based on one randomized 
clinical study or broad nonrandomized study.
39 Zoran Krivokapić, “ Early detection of colorectal cancer”, http://www.medicicom.com/content/view/282/64/, October 2009, ac-
cessed on January 13, 2011. godine
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3.6. The modalities of screening for people at an increased risk of developing colorectal cancer 
40  
Modality of screening for people with a genetic load for the occurrence of colorectal cancer 
(NHPCC, FAP, juvenile polyposis and Peutz-Jeghers syndrome) according to the National Guide for 
doctors in primary health care for the prevention of malignant diseases of the Ministry of Health of 
Serbia, includes a series of measures that ensure early detection and prevention for patients with the 
higher risk of developing this disease. 
1)  Persons and members of their families who are, based on the family anamnesis and clinical 
analysis, diagnosed with one of the abovementioned syndromes, need to be recorded into the registry 
by the family doctor /IIaB/
2)  It is necessary to refer these persons to a specialist of the tertiary institution, where molecular 
analysis will determine the presence of one of the mentioned syndromes. Additionally, persons with 
proven molecular disorders and members of their family need to be registered in the National Registry 
for hereditary tumor syndromes. /IIaB/ 
3) HNPCC (hereditary non-polyposis colorectal cancer)
•	Colonoscopy	once	every	2	years	starting	at	the	age	of	25	or	5	years	younger	than	the	age	of	the	
youngest cousin who is suffering from the colon cancer if that person is younger than 25. Monitoring 
is discontinued at the age of 75 or earlier if the absence of molecular mutations responsible for the 
development of the syndromes is confirmed. / IIaB /
4) FAP (familial adenomatous polyposis)
•	 For	 family	members	where	 genetic	mutations	 cannot	 be	 detected,	 it	 is	 necessary	 to	 perform	
sigmoidoscopy annually starting from the age of 13 to 15 until the age of 30, and then once every 3 to 
5 years until the age of 60. / IIaB /
•	For	family	members	where	the	existence	of	multiple	adenomatous	polyps	or	APC	gene	mutations	
are detected, preventive surgery of colon should be advised at the age between 16 and 20. / IIaB /
5) PJS (Peutz-Jeghers syndrome)
•	Colonoscopy	is	recommended	once	every	three	years,	starting	at	the	age	of	18.	/	IIbB	/	41     
6) JP (juvenile polyps)
•	Colonoscopy	is	recommended	once	every	1	to	2	years,	starting	at	the	age	of	15	to	18	or	earlier	if	
symptoms occur. / IIaB /
Recommendations for people with a positive family history of colorectal cancer, according to the 
clinical practice guidelines in oncology (National Cancer Comprehensive Network) for 2009 include:
1) For persons who have first-order relatives suffering from colorectal cancer aged between 50-60 
40 This group does not include persons diagnosed with inflammatory bowel disease.
41 Usefulness and efficiency of the proposed measures is less based on evidence or opinions. The data is based on randomized clini-
cal trials or extensive nonrandomized study.
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years, colonoscopy is recommended from 40 years of age, which is repeated every 5 years.
2) For persons who have first-order relatives suffering from colorectal carcinoma aged <50 years, a 
colonoscopy is recommended at the age of 40 or 10 years younger than the youngest member who is 
suffering from colorectal cancer. Colonoscopy should be repeated every 3-5 years.
3) For persons who have first-order relatives suffering from colorectal cancer at the age >60, 
colonoscopy is recommended starting at the age of 50, and should be repeated every 5 years.
4) For persons who have two first-order relatives diseased from the colorectal cancer at any age, 
colonoscopy is recommended at the age of 40 or 10 years younger than the youngest member who 
is suffering from colorectal cancer. Colonoscopy should be performed every 3-5 years after initial 
screening, depending on other familial predispositions.
5) For persons who have two second-order relatives diseased from the colorectal cancer at any age, 
colonoscopy is recommended at the age of 50, and should be repeated every 5 years.
6) For persons who have one first-order relative or one or more third-order relatives who are 
suffering from colorectal cancer, including first-order relatives suffering from noninvasive adenomas 
should be treated as patients with an average risk. Colonoscopy is the preferred screening method.
In Montenegro systematic preventive examinations at the primary health care level for early 
detection and prevention of colorectal cancer, are not implemented for groups of patients with genetic 
load for the development of colorectal cancer. 
3.7. Pilot project for early detection of colorectal cancer in the Municipality of Danilovgrad 
Ministry of Health and the Health Care Center Danilovgrad are implementing a pilot project - 
Program of early detection of colorectal cancer. This program covers a population of 2760 citizens 
living in the Municipality of Danilovgrad, aged between 50-74 years, with an average risk of colon 
cancer, without a positive history of polyps and/or colorectal cancer and no history of arthritis intestine 
(Ulcerative colitis, Crohn’s disease). 
Calls for screening for early detection of colorectal cancer defined by this project are sent to the 
home addresses of persons aged between 50-74 years, based on updated lists of the Ministry of Interior 
of Montenegro and the database of the Health Care Center Danilovgrad. With an invitation letter, 
the examinees receive tests and the instructions on the implementation of the test, corresponding 
questionnaire, flyer and educational brochure about the early detection of colorectal cancer, which was 
prepared by the Health Care Center Danilovgrad. 
All persons fill out the questionnaire that except for personal data on the person, contains information 
about the possible causes for the development of colorectal cancer: diet, lifestyle and habits (physical 
activity, smoking, alcohol), previous diseases of the colon (inflammatory bowel disease, polyps, cancer), 
and family anamnesis. The examinees are sent to their home address test on occult blood in the stool, 
instructions on how to implement the test as well as instructions on the preparation procedures before 
taking the test.  
In case of the positive tests the Health Care Center with the chosen doctor, delivers positive 
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tests on occult blood to home address, with an invitation to contact the chosen doctor for referral to 
colonoscopy, in order to find the cause of bleeding and possibly remove the risk of colon polyps, and 
so prevent the occurrence of colorectal cancer or detect the colon cancer at an early stage of growth.
The implementation of this program includes in addition to the Health Care Center, chosen 
doctors, nurses, visiting nurses, biochemists and technicians in the biochemical laboratory of the 
Health Care Center, subspecialists gastroenterologists and abdominal surgeons from the Clinical 
Center of Montenegro. 
This project, according to successful evaluation results that were presented in January 2011, 
represents a good basis for the creation of the Strategy for the implementation of early detection 
of colorectal cancer at the national level, which is in accordance with the Article 33 of the Law on 
Health Insurance. 
IV Regional overview
4.1 Serbia
Current situation in Serbia
According to the latest census from 2002, Serbia (without Kosovo) has an estimated population 
of 7.5m (5.466.000 in Central Serbia and 2.032.000 in Vojvodina). Compared to the 1991 census, 
the population was reduced by 4.4%. Furthermore, 30.000 people die of cancer in Serbia every year 
according to the Central Serbia Cancer Registry and Registry for malignant neoplasms of Vojvodina. 
42
According to the data for Serbian Registry of cancer, cardiovascular diseases and malignant tumors 
make over two thirds of deaths in 2009 in Serbia. More than half of all deaths (54.8%) are caused by 
blood vessel diseases, while every fifth of the death is caused by malignant tumors. From 2002 to 2009 
there was an increase of 3.6% in overall death rate in Serbia, closely connected to the frequency of 
deaths caused by leading noncommunicable diseases. The biggest increase in death rates happened in 
the cases of obstructive pulmonary diseases (26.3%), diabetes (23.2%), and malignant tumors (16.1%), 
whereas the death rates in the cases of heart and blood vessel related diseases were the least (2.8%).43 
Epidemiological situation of malignant tumors was until recently analyzed based on the death rate 
data, despite the fact that the Registry was established in 1970. The primary role of this Registry is to 
provide accurate count of all new cases of cancer, correct classification and coding, so as the data on 
cancer related deaths. Additionally, the Registry must have correct evaluation of the population under 
risk, in relation to the years of age and gender. However,  wrong management, insufficient education 
of health workers so as the lack of IT support resulted in sub-registration of new new-found  cases of 
cancer so as the low quality of data at the initial registration. In the period 1986-1995 the number to 
patients suffering from malignant tumors that were registered in the Registry was approximately the 
same of even lower than that of the number of patients died of cancer. That was the reason why the 
reorganization of Registry for Cancer was initiated. In the period 1996-2006, the Registry noted an 
42 National guidelines for primary care doctors, Prevention of malignant diseases, Ministry of Health, Serbia, November 2005
43 Health statistics of Republic of Serbia, 2009, Institute for Public Health, Belgrade 2010. ISSN 2217-3714
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increase in the rate of diseases. 44
In the year 200045  colon and rectum cancer was 5th on the list of causes of death accounting for 2.7 
%. Every year approximately 3800 cases of malignant colon tumors are registered while 2300 people 
dies of this type of cancer yearly. These numbers represent the second most commonly discovered 
cancerous disease in Serbia. In the year 200646 , colon and rectum cancer counted for the 11.9% of 
most common mortality causes after the lung cancer in men and breast cancer for women.  
In the territory of Central Serbia for the period 2002-2007, 24.493 people were diseased from 
malignant neoplasms, while 13.791 persons died. According to the data from the Registry of Cancer 
in Central Serbia, 25.662 persons were diseased in 2007, while 14.373 died. The incidence of this 
disease was 532.2 persons per 100.000. In the case of mortality caused by cancer, recorded death rate 
was 271.4 per 100.000 people, while the rate was 292.5 in the year 2009.47  According to the data of 
the cancer registry, the mortality in men was most present in the cases of bronchial and lung cancer, 
prostate cancer, colon and rectum cancer. In women, malignant tumor was most commonly localized 
in breast, cervix, colon and rectum.
Comparing to the nationals of other European countries, citizens of Republic of Serbia are in the 
medium rise for developing the disease and death caused by malignant diseases excluding lung and 
cervix cancer in which cases Serbia is one of the leading countries in Europe. 48 
4.1.1 Normative framework regulating the malignant neoplasm in Serbia 
The laws regulating the area of malignant diseases in Serbia are the Law on healthcare and Law on 
health insurance, which can be considered as general legislative acts regulating this area. Apart from 
these, there are also laws regulating the prevention, control and treatment of malignant diseases, such 
as the Law on data collections in the field of healthcare. Within the governmental framework for the 
development of health care, the Ministry of Health implements strategies important for prevention of 
malignant diseases: Strategy for prevention and control of chronic noncommunicable diseases 49 and 
the Poverty alleviation Strategy.50    
Serbian Government adopted the Poverty alleviation Strategy in 2003, which deals with poverty 
as s a multidimensional phenomenon. As such, poverty not only includes satisfaction of basic human 
needs, but also includes unemployment, accommodation and inadequate approach to social protection, 
health, educational and communal services. Related to the health care, the Strategy predicts better 
distribution of resources in order for preventive and primary health care to have high priority in the 
system of health protection. Additionally, the reform regulates financing of public health institutions, 
with the aim of providing prevention and early detection of diseases, especially for malignant and 
cardiovascular diseases.51  The primary goal is improvement of public health, decrease in inequalities 
in health, which is to be achieved through the improvement of status of vulnerable groups, including 
44 Cancer Registry, Institute for public health of Serbia, October 2006
45 National guidelines for primary care doctors, Prevention of malignant diseases, Ministry of Health, Serbia, November 2005
46 National Program for fight against cancer, Ministry of Health of Republic of Serbia
47 Health statistics of Serbia, Institute for Public Health of Serbia, ISSN 2217 - 3714
48 National program for the prevention of colorectal cancer, Ministry of Health of Republic of Serbia
49 Strategy for the prevention and control of chronic noncommunicable diseases of Republic of Serbia
50 Strategy for the poverty alleviation in Serbia, Belgrade 2003 
 Ibid.
51 Ibid.
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the diseased from malignant neoplasms. 
Apart from the aforementioned strategies, the Ministry of Health is implementing national 
programs and guidelines for prevention of malignant diseases, colon cancer in particular, such as the 
National program for cancer prevention52 , the National program for prevention of colorectal cancer53 
, the National guide for primary healthcare doctors54  and the National Guide for clinical practices. 55 
Paragraph 1, Article 11 of the Law on healthcare 56 stipulates that “social care for health, under 
equal conditions, in the territory of Republic of Serbia is achieved through providing health protection 
to those groups that are exposed to the increased risk of infection, health protection in relation to 
prevention, early detection and treatment of the diseases of wider social-medic importance, as well 
as the health protection of socially vulnerable population.” Healthcare of population affected by 
malignant diseases is regulated by the same Article, paragraph 2, point 5. Also, article 18, paragraph 
5 stipulates that it is in the public interest of the Republic of Serbia to implement monitoring and 
prevention of chronic noncommunicable diseases, including malignant neoplasms. This is achieved 
on the primary level of healthcare, regulated by the Article 88, paragraph 1, and point 4 of the Law 
on healthcare. Main principles of this law provides for integrated healthcare and prevention of both 
communicable and noncommunicable chronic diseases at the national level. The principles are: 
•	 Availability	of	healthcare,
•	 Equity	in	healthcare,
•	 Health	care	comprehensiveness
•	 Health	care	continuity	
•	 Health	care	quality	improvement
•	 Health	care	efficiency.
The Law on Healthcare further provides that the National Assembly shall adopt the Plan of 
development of health care (Article 16, paragraph 1). The development plan is based on the analysis 
of population health, the population needs for healthcare, and available human, financial and other 
capacities (Article 17, paragraph 1). One of the main objectives of the Plan of development of 
healthcare of Serbia 2010 – 201557 , is to reduce morbidity and premature mortality from malignant 
disease. Following activities are being implemented: 
•	Implementation,	monitoring	and	evaluation	of	National	Program	“Serbian	against	cancer”;	
•	Implementation,	monitoring	and	evaluation	of	National	Program	for	prevention	of	breast	cancer;	
•	 Implementation,	monitoring	 and	 evaluation	 of	National	 Program	 for	 Prevention	 of	Cervical	
Cancer;	
•	 Implementation,	monitoring	and	evaluation	of	National	Program	for	Prevention	of	colorectal	
cancer 
Article 16, paragraph 2 of the Law on healthcare stipulates that the Government adopts relevant 
programs with the aim of implementing the Plan of development of healthcare. Some of the programs 
that the Government adopted in relation to the prevention, early detection and control of malignant 
diseases are: National program for the prevention of cancer, National program for the prevention of 
52 National program for cancer prevention, Ministry of Health of Republic of Serbia
53 National program for the prevention of colorectal cancer, Ministry of Health of Republic of Serbia
54 National guide for primary healthcare doctors, Prevention of malignant diseases, Ministry of Health of Serbia, November 2005
55 National guide for clinical practice, Minimal clinical reccomendations for diagnosis, treatment and monitoring, Ministry of Health 
of Serbia, September 2002
56 The Law on healthcare, Government of Serbia,  “Official Gazzete of Serbia“, numbers 107/05 and 72/09
57 Plan of development of healthcare in Serbia 2010-2015, Ministry of health of Serbia
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colorectal cancer, National program “Serbia against cancer” and National program for testing the 
colon cancer. 58 
Article 22, paragraph 1 of the Law on health insurance stipulates that the beneficiaries of 
mandatory health insurance are: persons who belong to groups that are exposed to increased risks 
of developing the disease, persons who need healthcare in relation to the prevention, early detection 
and treatment of diseases of broader socio-medical significance, as well as socially vulnerable persons. 
Point 5 of the same article includes persons diseased from malignant neoplasms. 
4.2. Croatia
Current situation of malignant diseases in Croatia
Cancer is an important health issue for the citizens of Croatia. It represents the second most 
important	cause	of	death,	right	after	cardio-vascular	disease;	therefore	it	is	very	important	to	assess	the	
actual data which would help devise a strategy for prevention and protection. Only a well-organized 
registration of cancer can ensure assessing that data. Consequently, the incidence and mortality rates 
from cancer in Croatia are monitored and studied by the State Registry for cancer, a population 
registry established within the Croatian Institute for Public Health. Registry for Cancer of Croatia 
was founded in 1959. Starting from 1968, the data are being processed electronically. From 1994, the 
Registry is a full member of the International Association of Registries for Cancer in Lyon, France. 
By participating in the European Network of Cancer Registries (ENCR), the Registry became an 
integral part of the incidence and mortality from cancer database (EUROCIM).
The first cause of death in Republic Croatia in 2009 were cardio-vascular diseases, with fatal 
outcome for 25.976 persons or 586.5/100000 citizens. From malignant neoplasm, the second group 
of diseases which are the leading causes of death, 13 496 people passed away, or 304.7/100 000 
citizens. Three quarters of all causes of death in Croatia belongs to these two groups, while the rest of 
the causes are related to injuries and poisoning, gastrointestinal problems, lung diseases and other less 
prevalent causes.59 
According to the data of the Cancer Registry of the Croatian Institute for Public Health, intestinal 
cancer is a second most frequent form of cancer among men (after the lung cancer) and women (after 
the breast cancer) which overall represents 15% of men and 13% of women. In the period from 1983 
to 2004 the number of new cases of intestinal cancer increased from 1 186 to 2 653 (124%), and 
the number of deceased increased from 840 to 1 564 (86%). From recently discovered 2653 patients 
throughout 2004, 1 531 are men and 1 122 are women. The main reason for a continuous rise in 
mortality is the condition of the intestinal cancer at the moment of diagnosis – only less than 10% of 
all the carcinoma was localized on the intestinal wall. For the last few years a more adequate treatment 
of this disease can be noted, since there was an increase in the five-year survival of gastrointestinal 
cancer from 35% to 39% for men and from 35% to 42% for women. 60
58 National Program for testing the colon cancer – Informative brochure, ISBN: 1-74186-606-5, ISBN: 1-74186-607-3, Number of 
publication: P3 - 386
59 The report about deceased people in Croatia in 2009 ,  http://www.hzjz.hr/publikacije/umrli_2009.pdf
60 Cancer Registry of Republic Croatia http://www.hzjz.hr/rak_index.htm
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4.2.1 Legal Acts which regulate malignant neoplasm in Croatia
The laws which regulate prevention and control of malignant neoplasm in Croatia are the Law on 
Public Protection61 , the Law on mandatory health insurance62 , the Law on protection of the rights of 
patients63  as well as numerous national strategies and programs conducted by the Ministry of Health 
and Social care. 
National strategy of health development 2006-201164 , brought by the Croatian Sabor on July 
9th 2006, envisions that a decrease in mortality caused by malignant diseases can be achieved by early 
tumor discovery programs like
•	 Program	for	early	breast	cancer	discovery	in	2006
•	 Program	for	early	intestinal	cancer	discovery	in	2007
•	 Program	of	early	ovarian	cancer	discovery	in	2009
•	 Program	of	early	prostate	cancer	discovery	in	2009
All these programs are already under way in Croatia.
As a part of the Strategic plan from 2010 –201365 , conducted by the Ministry of Health and Social 
Care believes that in the interest of protection and development of health it is essential to promote 
healthy lifestyles which will make an impact on the quality and longevity of life, a decrease in chronic 
non-contagious diseases as well as some malignant diseases. The Ministry of Health and Social Care 
will continue with previously started programs of early breast cancer and intestinal cancer discovery 
and begin with new programs for discovering cancer. As one of the benchmarks of the Plan success 
are early discovered carcinoma and for ensuring an implementation of this type of protection of the 
public health interests, an increase in the outcome of gastrointestinal bleeding testing was planned, 
which would represent a continuation of the previously activated programs regarding the early cancer 
development and newly founded malignant diseases monitoring.
The Ministry for Health and Social Care of Croatia also conducts the National program of early 
intestinal cancer development 66. This program makes a significant contribution to the improvement 
of the population health because by preventive measures malignant intestinal tumors are discovered 
in their early stadiums, in the stadium of premalignant lesions or early carcinoma, when the 
probability for a successful treatment is large. This program should include the whole targeted 
population and all the citizens need to have an equal opportunity to participate in the program, 
including the socially endangered ones. The goals of the Program are:
•	 To	decrease	the	mortality	from	intestinal	cancer	at	least	for	15%	in	the	next	five	years	after	the	
program has been conducted
•	 To	test	at	least	the	60%	of	the	invited	people
•	 To	discover	cancer	in	its	early	stadiums	and	therefore	enhance	the	possibility	of	curing	the	
diseased and improving their lifestyle
•	 To	analyze	75%	of	the	risky	groups	in	the	population	with	early	cancer	discovery	by	2015
This Program has also presented preventive measures and early intestinal cancer discovery. Those 
61 Law on public protection, Croatian Sabor, Zagreb, January 15th, Class 500-01/08-01/03
62 Law on mandatory health insurance, Zagreb, January 15th, Class 500-01/08-01/12
63 The law on the protection of the rights of patients, Zagreb, December 24,  2004, Number: 01-081-04-3610/2
64 National strategy of health development 2006-2011, Croatian Sabor, 2006
65 Strategic plan 2010 – 2013, Ministry of Health and Social Care of Croatia
66 Program for early intestinal cancer development, Ministry for Health and Social Insurance of Croatia, Zagreb, 2007
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are mostly tests of occult fecal bleeding, proctosigmoidoscopic test and colonoscopy with twofold 
contrast as well as determination of tumorous markers. The whole process begins with a media 
campaign about the prevention and early intestinal cancer development and encouraging people older 
than 50 to get tested. The call for testing is sent to the home addresses of the persons between 50 and 
74 based on the census. Along with the invitation, a brochure explaining the Program, a survey to 
determine if that person is a potential member of the risk group and potential risk factors for the start 
of the disease are sent. The invitation also contains the manual for the performing of the test and three 
more test on a presence of occult blood in stool. The testing is conducted at home and it is delivered 
for results after one or two days to the Institute for Public Health of Zagreb, after which the Institute 
arranges a check for the individuals with positive test results and delivers a call for colonoscopy and 
guidelines for preparation to the home address. The results of testing, survey papers as well as suitable 
diagnostic findings are collected and analyzed by local institutes for public health, and the monitoring 
and evaluation are conducted by the Croatian Institute for Public Health.
4.3 Bosnia and Herzegovina 
 Current situation of malignant diseases in Bosnia and Herzegovina
The health condition of Bosnia and Herzegovina Federation citizens is characterized by important 
demographic changes, significant presence of chronic diseases and a high prevalence of unhealthy life 
habits67 . With already prevalent health issues, new ones are occurring, which deteriorates the health 
of Bosnia and Herzegovina citizens. Negative health indicators like mortality and morbidity are used 
in order to rate the health condition of the citizens, as well as other indicators of the recent research.
In 2007, mortality rate had a mean of 8.3‰ and displays a slow but continuous growth as a 
reflection of the aging of the citizens. The lead causes of death in 2007 are circulatory system diseases 
(54.3%), with the second cause being malignant neoplasm with 19.1%, which means that almost 
three quarters of all the causes of death are in these two groups. The diseases of endocrine system 
and metabolism with eating disorders are also highly ranked with 4.0%. A direct consequence of the 
negative prevalence of the risk factor is noted, as well as an increase in the chronic diseases among 
the population. Comparing standardized mortality rates from malignant neoplasm with the countries 
in the region, Bosnia and Herzegovina has a low death rate of 137.9/100 000 citizens, as opposed to 
Croatia whose malignant neoplasm mortality rate is 210.24/100 000 citizens.
Five leading causes of death from malignant neoplasm in Bosnia and Herzegovina in 2007 
were malignant neoplasm of bronchi and lungs with 26.3 %, then malignant neoplasm of liver and 
intrahepatic gallbladder (7.4%), followed by gastritis malignant neoplasm. Among men, who die more 
frequently from malignant neoplasm than women, the lead causes of death are malignant neoplasm of 
bronchi and lungs with 36.2%, followed by gastrointestinal and prostate malignant neoplasm. Among 
women, the lead cause of death from malignant neoplasm is malignant neoplasm of breast (14%). 
Malignant neoplasm of bronchi and lungs are also highly ranked (12.2%) 68
Because of the significance of malignant neoplasm in morbidity and mortality in Bosnia and 
Herzegovina, a population registry has been established. The first results of the population registry 
of malignant diseases in Bosnia and Herzegovina for the year 2005 “CanReg4” showed that the 
overall rate in 2005 was 170,18/100 000 citizens. Intestinal cancer is one of the most frequent forms 
67 The report about deceased people in Croatia in 2009 ,  http://www.hzjz.hr/publikacije/umrli_2009.pdf
68  Cancer Registry of Republic Croatia http://www.hzjz.hr/rak_index.htm
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of carcinoma, which equally attacks both genders in this country with a high death rate. Also, by 
introducing the register it has been noticed that the frequency of intestinal carcinoma has been 
continuously and significantly increasing and that there are indications that this type of cancer 
will soon become the most frequent form of carcinoma in Bosnia and Herzegovina. According 
to the International agency for cancer investigation from Lyon, 663 newly founded diseased from 
colorectal carcinoma among the female population is expected, with 826 diseased among the male 
population. 836 deaths, caused by this disease, are expected yearly. 69
4.3.1 Legal acts that regulate malignant neoplasm in Bosnia and Herzegovina
The Federation of Bosnia and Herzegovina bases its laws in the area of health on international 
conventions, declarations and treaties. Two essential laws that are regulating this area are the Law on 
health insurance and the Law on health protection.70 In the article 8, Law on the health protection 
, it is stated that the Federation of Bosnia and Herzegovina, as a part of activities designated from 
the field of health protection, is obliged to ensure malignant diseases prevention, and based on the 
article 16, point 5, it is obliged to enforce measures and activities for prevention, early discovery 
and moderation of contagious, chronic, mass non-contagious and malignant diseases. Law on health 
insurance71 , article 32, states that health protection entails treatment of malignant diseases. The Law 
on rights, obligations and responsibilities of the patients72  and the Law on records in the area of 
health73  also entails the area of prevention, treatment and control of malignant diseases. Apart from 
the law, the Government of the Federation and the Ministry of Health are bringing strategies and 
programs important for prevention and control of malignant diseases. Some of them are: Strategy 
for development of primary health protection74 , Strategic plan of health development in Bosnia and 
Herzegovina Federation in the period from 2008 to 201875  and the Program for prevention and early 
discovery of intestinal cancer. 
The government of federation of Bosnia and Herzegovina brought the Program for prevention and 
early discovery of intestinal carcinoma, through which was also brought the Guide for prevention and early 
discovery of intestinal carcinoma76 , which goal is to point out the possibility of efficacious and safe 
method of prevention and early discovery of the intestinal cancer in the easiest way. The goals of using 
the Guide are:
- To lower the frequency of intestinal cancer by designated preventive methods, especially by 
giving advice on diet and healthy lifestyle
- Premalignant lesions can be diagnosed and removed with frequent and proper screening, 
thereby lowering the frequency of the intestinal cancer
- By conducting screenings, malignant diseases can be revealed in an early stage, which ensures 
an improvement of colorectal carcinoma treatment
69 Law on public protection, Croatian Sabor, Zagreb, January 15th, Class 500-01/08-01/03
70 Law on mandatory health insurance, Zagreb, January 15th, Class 500-01/08-01/12
71 The law on the protection of the rights of patients, Zagreb, December 24,  2004, Number: 01-081-04-3610/2
72 National strategy of health development 2006-2011, Croatian Sabor, 2006
73 Law on record in the area of Health “Official Gazette of Bosnia and Herzegovina” no. 2/92 and 13/94
74 Strategy for the development of primary health protection, Federal Ministry of health, Federation of Bosnia and Herzegovina
75 Strategic plan of health development in Federation of Bosnia and Herzegovina in the period from 2008 to 2018, Federal Ministry 
of Health, Federation of Bosnia and Herzegovina
76 Guide for prevention and early discovery of gastrointestinal carcinoma ISBN 978-9958-695-15-5 (Ministry of Health KS)
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The methods of early intestinal cancer discovery which are envisaged by the Guide are: stool 
testing on occult bleeding, colonoscopy, digital rectal check as well as carcino-embryonic antigen 
(CEA). It is estimated that the testing would decrease the mortality caused by colorectal carcinoma if 
the person, age 50 to 80, would undergo it at least once a year or once in two years on the samples of 
diluted or undiluted stool. The possibility of monitoring high-risk patients for colorectal carcinoma 
increased the discovery of neoplasm in the early operable stage of the disease. 
With regards to the probability of intestinal carcinoma, the population is divided into three risk 
groups. In the first group are the people with a high risk that have intestinal diseases, inherited 
polyposis, early colorectal carcinoma, early adenoma polyp or symptoms and signs that incite 
suspicion on the intestinal tumor. In the other group, with a more moderate risk, are people older 
than 45 without symptoms or signs that incite suspicion on the intestinal tumor, while in the last 
group are people with a low level of risk, asymptomatic persons younger than 45. To the asymptomatic 
persons and persons with a moderate risk, testing on the occult bleeding is suggested at least once a 
year, starting from the age of 45. They are also suggested to start colonoscopy from 45, so if the two 
checks in the two years are negative, the checks should be continued every 3-5 years. Yearly testing 
on the occult blood is recommended to the people with a higher risk, colonoscopy to the persons who 
previously suffered a colorectal carcinoma and early adenoma polyp, while the persons with inherited 
polyposis is suggested to start screening in their 14th year, including the family.  
V Conclusion and recommendations
Proposed measures for implementation of the prevention and early detection of colorectal cancer in 
Montenegro
The issue of prevention and early detection of colorectal cancer in Montenegro is legally 
established, while there are no mechanisms necessary for the proper implementation. The lack of 
the Registry substantially prevents the monitoring and implementation of planned activities, which 
further complicates planning and systematization of health care. The preparation of national clinical 
practice guidelines on prevention, diagnosis and treatment of colorectal cancer is a prerequisite for 
the preparation of the National program of prevention and early detection of colorectal cancer. 
Early detection of colorectal cancer should be provided through the implementation of preventive 
examinations, as well as development of screening modalities for categories of patients at average and 
increased risk of developing the disease. Categorization of patients in terms of the risks for developing 
the disease, it is necessary to prepare and distribute brochures and questionnaires at the National 
level, and update the Registry with obtained data. Finally, introduction of molecular analysis for 
determining the genetic load for some hereditary factors that lead to the development of this disease, 
would significantly contribute to reducing the medical costs. 
5.1 Legal regulation of early detection of colorectal cancer at the primary health care level 
Article 33 of the Law on Health Care Law defines health services that are implemented at the 
primary health care level, which include detection, prevention and control of malignant diseases. The 
Law on Health Insurance further defines medical measures and procedures for prevention, suppression 
and early detection of malignant diseases (Article 17). Finally, the article 12 of the Regulation on the 
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extent of rights and standards of health care and mandatory health insurance regulates the preventive 
screenings of cervical and breast cancers. Consequently, preventive screenings for early discovery of 
colorectal cancer at the primary health care level are not implemented, even though such obligation 
is legally established. 
Problem: Failure to meet legal obligations defined by the Article 33 of the Law on Health Care 
and Article 17 of the Law on Health Insurance.
The consequence: The lack of implementation of early detection of colorectal cancer at the level 
of primary health care. 
Objective: The establishment or amendments of a legislative framework for the early detection of 
colorectal cancer at the level of primary health care. 
Measures: 
1. Adoption of regulation in accordance with the Article 33 of the Law on Health Care, which 
would regulate preventive examinations in terms of early detection of colorectal cancer at the primary 
health care level. 
2. Amendment of the Article 12 of the Regulation on the extent of rights and standards of health 
care and mandatory health insurance, which would include preventive screening tests for colorectal 
cancer. 
5.2 Registry for colorectal cancer 
 Problem: Failure to fulfill legal obligation of establishing the Registry of malignant neoplasms in 
Montenegro.
The consequence: Difficulty for systematization of prevention and early detection of colorectal 
cancer 
Objective: Establishment of the National Registry for malignant diseases, which would include 
information on colorectal cancer and establishment of a Registry for hereditary tumor syndromes. 
Measures: 
3. Implementation of the legal obligations defined by Articles 2, 8 and 9 of the Law on data 
collections in the field of health, in terms of preparing the National Registry for malignant neoplasms, 
including colorectal carcinoma. 
4. Implementation of the legal obligations defined by Articles 2, 8 and 9 of the Law on data 
collections in the field of health, in terms of preparing the Registry for hereditary tumor syndromes.
5.3 National clinical practice guidelines for the prevention and diagnosis of colorectal cancer 
in Montenegro 
Problem: Lack of national clinical practice guidelines for the prevention and diagnosis of colorectal 
carcinoma. 
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The consequence: Lack of clearly defined clinical recommendations for the prevention and 
diagnosis of colorectal carcinoma.
Objective: Preparation of national guidelines that would define the procedures on prevention of 
colorectal cancer. 
Measure:
5. Improvement of the existing health system in Montenegro, through preparation of national 
clinical practice guidelines on the prevention and diagnosis of colorectal cancer, by eminent experts in 
this field, which would be in accordance with European recommendations
5.4 Screening tests for persons at average risk of developing colorectal cancer at the primary 
health care level 
Problem: Lack of preventive examinations in primary health care for persons with average risk of 
developing colorectal cancer 
The consequence: Failure to achieve early detection of colorectal cancer for patients without 
symptoms and risk factors, resulting in late detection of colorectal cancer. 
Objective: Implementation of preventive examinations in primary health care for persons with 
average risk for developing colorectal cancer, with the aim of detecting bowel polyps and colorectal 
cancer in early stages. 
Measures:
6. The implementation of screening modalities for persons at average risk for developing this disease, 
through fecal occult blood testing. The target population includes males and females aged between 
50-74, without personal anamnesis of polyps and/or colorectal cancer, no anamnesis of inflammatory 
bowel disease and no family anamnesis of colon cancer. 
7. Preparation and distribution of flyers and brochures on early detection of colorectal cancer, at 
the national level 
8. Preparation and invitations for occult blood testing 
9. Preparation and distribution of questionnaires on the existence of risk factors for colorectal 
cancer 
10. Supply and distribution of tests for occult blood in the stool to home addresses  
11. Processing of the questionnaires and updating of the Registry for colorectal cancer  
5.5 Center for the implementation of molecular analysis on the presence of gene load/inherited 
syndromes that lead to the development of colorectal cancer
Problem: The lack of molecular analysis that helps determine gene load/hereditary syndromes, 
which lead to the development of colorectal cancer
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The consequence: Referral of patients abroad to perform molecular analysis and significantly 
increased cost of diagnosis 
Objective: Implementation of molecular analysis on hereditary tumor syndromes that lead to the 
development of colorectal cancer. 
Measures:
12. Expanding the activities of the Center for Genetics of the Clinical Center of Montenegro, so 
that it includes genetic analysis of hereditary non-polyposis colorectal cancer, familial adenomatous 
polyposis, Peutz-Jeghers syndrome and juvenile polyposis. 
5.6 Screening tests for persons at an increased risk of developing colorectal cancer at the 
primary health care level
Problem: Lack of preventive examinations in primary health care for persons with an increased 
risk of developing colorectal cancer
The consequence: Failure to achieve early detection of colorectal cancer for patients with an 
increased risk for developing colorectal cancer 
Objective: Implementation of preventive examinations in primary health care for persons with an 
increased risk for developing colorectal cancer, with the aim of polyposis and colorectal cancer in the 
early stages, when complete healing is possible. 
Measures:
13. The introduction of criteria for the classification of persons with increased risk of suffering from 
KRK
14. Production and distribution of flyers and brochures on early detection of colon cancer
15. Creating and sending a questionnaire about possible risk factors for developing colon cancer, 
which include providing information on the existence of a positive family burden of colorectal cancer, 
and genetic load of pre-cancerous diseases.
16. Updating the Register for colorectal cancer and hereditary Registry tumor syndromes data 
collected questionnaires
17. Referral of patients by doctors selected in the third level institution to perform molecular 
analysis of belonging to one of the above syndrome, and then possibly to colonoscopy according to 
established criteria.
13. The introduction of criteria for the classification of persons with an increased risk for the 
development of colorectal cancer 
14. Preparation and distribution of flyers and brochures on early detection of colorectal cancer 
15. Preparation and distribution of questionnaires about possible risk factors for the development 
of colorectal cancer, which would include information on the existence of a positive family burden of 
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colorectal cancer and genetic load of pre-cancerous diseases. 
16. Update of the Registry for colorectal cancer and the Registry for hereditary tumor syndromes 
based on the data collected from questionnaires. 
17. Referral of patients by chosen doctors to the third level institutions to perform molecular 
analysis with the aim of determining the presence of syndromes, or colonoscopy. 
5.7 Education and training of gastroenterologists for performing the colonoscopy 
In Montenegro, there are not enough gastroenterologists appropriately trained to perform 
colonoscopy, which is one of the prerequisites for successful screening. Education of doctors is one 
solution to this problem.
Problem: Lack of adequately trained subspecialist gastroenterologists to perform endoscopic 
procedures.
The consequence: Percentage of achieved total colonoscopies is below international standards
Objective: Implementation of adequate, total colonoscopies 
Measure: 
18. Education of medical personnel and training of gastroenterologists in the renowned endoscopic 
centers in the region, as well as in the EU countries.
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About organisations
Coalition for Social Changes was established on the 15th of December 2009, among ten leading 
organizations of civil society in the area of health, social protection, labor market and education: The 
Monitoring Center, AD Center Equista, Center for Civic Education, Juventas, CAZAS, Institute 
for Social inclusion, Pedagogical Centerof Montenegro, Montenegrin Association of Youth with 
Disabilities, Association of parents of Children with Disabilities „Sunbeam“. The Coalition is open for 
who all interested organizations of civil society, dealing with problems of poverty and social exclusion, 
can freely join. Main aim of forming of the Coalition is contribution to stregthening of advocacy 
capacities and watchdog functions of civil society organizations in Montengro, in order to influence
creation of policies and laws in the area of education, labor market, social and children’s
protection.
Juventas
Juventas is a non-profit organization established on January 29th, 1996 in Podgorica. 
Juventas envisages Montenegro as a stable, democratic society in which young people can freely 
express utilize their potential. Some of the goals of Juventas are: to stimulate critical thinking 
and develop a culture of dialogue, promotion of culture, peace, tolerance and peaceful conflict 
resolution, promotion of human rights, healthy lifestyles, and fight against drug abuse. More 
information at www.juventas.co.me 
The Monitoring Center – CEMI 
The Monitoring Center – CEMI is a nongovernmental, non-profitable organization founded in 
May 2000, whose main goal is to provide infrastructural and expert support for continuous monitoring 
of the process of transition in Montenegro. CEMI envisages Montenegro as a land of free citizens, 
the rule of law, social justice and equal opportunities. The mission of CEMI is to continuously provide 
support to reforms and strengthening of institutions of political system and civil society organizations, 
by proposing and monitoring the implementation of public policies in the fields of human rights and 
freedoms, fight against corruption and Euro-Atlantic integration of Montenegro. CEMI implements 
its activities through three programs: Democratization and human rights, Fight against corruption 
and European Integration, while the organizational structure consists of four departments: Public 
policy research department, Legal department, Public opinion survey department and Public Relations 
Department. More information at: www.cemi.org.me
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